LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Replicate Assay Well Timepoint Timepoint Unit Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Relative Growth Rate After Treatment
BT-20 SU11274
3.33
uM
LJP5
2
J08
72
hr
1657 4803 5505 0.8724 0.8174
BT-20 SU11274
3.33
uM
LJP5
3
J08
72
hr
1657 4656 5505 0.8457 0.7792
BT-20 Fedratinib
3.33
uM
LJP5
1
L02
72
hr
1657 3765 5505 0.6838 0.5476
BT-20 Fedratinib
3.33
uM
LJP5
2
L02
72
hr
1657 3942 5505 0.7160 0.5936
BT-20 Fedratinib
3.33
uM
LJP5
3
L02
72
hr
1657 3902 5505 0.7087 0.5832
BT-20 TGX221
3.33
uM
LJP5
1
H20
72
hr
1657 5513 5505 1.0013 1.0019
BT-20 TGX221
3.33
uM
LJP5
2
H20
72
hr
1657 5721 5505 1.0391 1.0560
BT-20 TGX221
3.33
uM
LJP5
3
H20
72
hr
1657 5434 5505 0.9870 0.9814
BT-20 Torin1
3.33
uM
LJP6
1
O14
72
hr
1657 1051 5505 0.1909 -0.1577
BT-20 Torin1
3.33
uM
LJP6
2
O14
72
hr
1657 1169 5505 0.2123 -0.1270
BT-20 Torin1
3.33
uM
LJP6
3
O14
72
hr
1657 1500 5505 0.2725 -0.0410
BT-20 Torin2
3.33
uM
LJP5
1
I20
72
hr
1657 1078 5505 0.1958 -0.1507
BT-20 Torin2
3.33
uM
LJP5
2
I20
72
hr
1657 1111 5505 0.2018 -0.1421
BT-20 Torin2
3.33
uM
LJP5
3
I20
72
hr
1657 963 5505 0.1749 -0.1806
BT-20 Tozasertib
3.33
uM
LJP5
1
B14
72
hr
1657 1638 5505 0.2975 -0.0051
BT-20 Tozasertib
3.33
uM
LJP5
2
B14
72
hr
1657 1527 5505 0.2774 -0.0340
BT-20 Tozasertib
3.33
uM
LJP5
3
B14
72
hr
1657 1716 5505 0.3117 0.0151
BT-20 Trametinib
3.33
uM
LJP5
1
P20
72
hr
1657 4075 5505 0.7402 0.6282
BT-20 Trametinib
3.33
uM
LJP5
2
P20
72
hr
1657 3989 5505 0.7245 0.6059
BT-20 Trametinib
3.33
uM
LJP5
3
P20
72
hr
1657 4398 5505 0.7988 0.7121
BT-20 TWS119
3.33
uM
LJP5
1
M02
72
hr
1657 4727 5505 0.8586 0.7976
BT-20 TWS119
3.33
uM
LJP5
2
M02
72
hr
1657 4049 5505 0.7354 0.6214
BT-20 TWS119
3.33
uM
LJP5
3
M02
72
hr
1657 4625 5505 0.8400 0.7711
BT-20 Vemurafenib
3.33
uM
LJP5
1
C14
72
hr
1657 5379 5505 0.9770 0.9671
BT-20 Vemurafenib
3.33
uM
LJP5
2
C14
72
hr
1657 4873 5505 0.8851 0.8356